stockrow
Saturday 7 November 2026
Export CTY’s income statement to Excel — free account
City Therapeutics, Inc
18.56
1.49
+8.73%
Follow CTY
Alert me
City Therapeutics, Inc (CTY) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| ODTX Odyssey Therapeutics, Inc. compare | n/m |
| GLUE Monte Rosa Therapeutics, Inc. compare | n/m |
| ORIC Oric Pharmaceuticals, Inc. compare | n/m |
| SVRA Savara Inc. compare | n/m |
| JBIO Jade Biosciences, Inc. compare | n/m |
| IVA Inventiva S.A. Sponsored ADR compare | n/m |
| PHAR Pharming Group N.V. Sponsored ADR compare | 34.2× |
| LTGO Latigo Biotherapeutics Inc compare | — |
| CTY City Therapeutics, Inc | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)